The most important differential diagnosis of TCC and prostate adenocarcinoma is an IHC panel which includes Leu7 (human natural killer-1), PSAP, PSA, P63, CK7, and CK34BE12. This evidence concerns the gene KLK3 and prostate adenocarcinoma.